These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 10841130
1. Reversible ageusia as an effect of clopidogrel treatment. Golka K, Roth E, Huber J, Schmitt K. Lancet; 2000 Feb 05; 355(9202):465-6. PubMed ID: 10841130 [Abstract] [Full Text] [Related]
2. Reversible ageusia associated with clopidogrel treatment. Koc F, Ozeren A. Neurol India; 2006 Jun 05; 54(2):218-9. PubMed ID: 16804280 [No Abstract] [Full Text] [Related]
3. [Reversible ageusia associated with clopidogrel use]. Miranda MC. Rev Med Chil; 2012 Sep 05; 140(9):1230-1. PubMed ID: 23354649 [No Abstract] [Full Text] [Related]
6. Reversible shortness of breath caused by the antiplatelet agent, clopidogrel. Yi HJ, Cheong MA, Kim DW. J Neurosurg Anesthesiol; 2013 Jan 05; 25(1):86-7. PubMed ID: 23027227 [No Abstract] [Full Text] [Related]
7. Fatal aplastic anaemia associated with clopidogrel. Trivier JM, Caron J, Mahieu M, Cambier N, Rose C. Lancet; 2001 Feb 10; 357(9254):446. PubMed ID: 11273071 [Abstract] [Full Text] [Related]
8. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost? Black C, Paterson KR. Adverse Drug React Toxicol Rev; 2001 Dec 10; 20(4):277-303. PubMed ID: 11770173 [No Abstract] [Full Text] [Related]
9. Bioequivalence in the real world is a complex challenge: the case of clopidogrel. Marcucci R, Paniccia R, Gori AM, Gensini GF, Abbate R. J Am Coll Cardiol; 2013 Feb 05; 61(5):594-5. PubMed ID: 23246390 [No Abstract] [Full Text] [Related]
10. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, Hirano M, Shinohara Y, Matsumoto M, Yamaguchi T. Cerebrovasc Dis; 2008 Feb 05; 25(1-2):40-9. PubMed ID: 18033957 [Abstract] [Full Text] [Related]
11. Response variation in patients treated with clopidogrel. Thethi I, Messmore H, Fareed J. Clin Appl Thromb Hemost; 2010 Aug 05; 16(4):483-4. PubMed ID: 20647228 [No Abstract] [Full Text] [Related]
12. The CAPRIE trial: culmination of the preregistration program for clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Clopidogrel versus aspirin in patients at risk of ischaemic events. Gent M. Semin Thromb Hemost; 1999 Aug 05; 25 Suppl 2():1-2. PubMed ID: 10440414 [No Abstract] [Full Text] [Related]
13. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. David JL, Limet R. Thromb Haemost; 1999 Nov 05; 82(5):1417-21. PubMed ID: 10595630 [Abstract] [Full Text] [Related]
14. How long should we delay hip fracture surgery for elderly patients on clopidogrel? Haidar R, Taher AT. Injury; 2011 Dec 05; 42(12):1509-10. PubMed ID: 20637460 [No Abstract] [Full Text] [Related]
15. Ticlopidine as a safe alternative for clopidogrel-associated arthritis. Khan EA, Blake JW, Stamp LK. J Rheumatol; 2009 Apr 05; 36(4):855-6. PubMed ID: 19342727 [No Abstract] [Full Text] [Related]
19. Myelodysplastic syndrome associated with clopidogrel: a case report. Li M, Chen T, Liang C, Xiang X, He Z, Wu Z. Int J Clin Pharmacol Ther; 2012 Jan 05; 50(1):44-6. PubMed ID: 22192644 [Abstract] [Full Text] [Related]